| Similar Articles |
|---|
 |
Bio-IT World
April 2006
Michael A. Greeley |
The Good, The Bad, and The Ugly VCs will not support a sector where consistent compelling exits are not evident. Unfortunately, the bio-IT field still suffers from this.   |
Bio-IT World
July 15, 2003
Michael Greeley |
Finally, the Bottom Has pharma bought all the solutions it needs? The flood of genomic data indicates no. |
Bio-IT World
January 13, 2003
Michael Greeley |
What Do We Do Now? Like it or not, the supply of capital is an important ingredient in the continued development of the bio-IT industry. Appreciating and understanding the forces currently at work in the VC marketplace can only help in raising capital. |
Bio-IT World
April 15, 2003
Michael Greeley |
Bio Battles Upstream As biotech business models evolve, the question remains: Which will survive? |
Bio-IT World
October 10, 2003 |
Funds Up Venture financing numbers are in for Q2, and the news is not all bad. |
Bio-IT World
Jul/Aug 2006
Michael A. Greeley |
Monsoon of Capital The private equity markets, both venture capital and growth equity, while characterized by a number of established firms, continue to struggle with how best to finance early-stage, risky bio-IT companies. |
Bio-IT World
September 11, 2003 |
Show Me the Evidence ... Some emerging bio-IT services companies are beginning to attract venture capital. |
Bio-IT World
March 10, 2003
Michael Greeley |
Too Much Informatics Did bioinformatics companies forget about the fundamental law of supply and demand? |
Bio-IT World
October 14, 2004
Michael Greeley |
Go East Business is great in China, and the government is strongly encouraging the local biotech industry. |
Bio-IT World
June 2005
Michael A. Greeley |
Who Wants to Be a VC? The objective is to stay relevant to a venture firm while the industry contracts. Develop the case that you can help create great companies (and great returns) because you have built a Rolodex and an ability to identify patterns of success. |
InternetNews
November 5, 2010 |
VC Spending Plummets But Software Still Tops The third quarter was a disappointing one for venture capital investment but a good number of new software companies have little to complain about. |
Bio-IT World
February 10, 2003
Michael Greeley |
The Upside of the Downturn Biotech entrepreneurs need to rethink how they raise capital and craft business model frameworks. |
Bio-IT World
May 9, 2003
Michael Greeley |
Mechanistic Models Investors are backing predictive modeling software that could speed drug development. |
Entrepreneur
February 2009
Guy Kawasaki |
Top 9 Lies of Venture Capitalists Here's a look at the meanings behind what VCs say. |
| Knowledge@Wharton |
Venture Capitalists: More Caution, More Due Diligence, More Diversity Venture money is out there, but it will be staying more and more with entrepreneurs who have better grounding, better products and at least a modicum of a track record... |
Wired
April 2004
Gary Rivlin |
The Roots of Bust 2.0 Suddenly, venture capital is growing on trees. But the cash glut could crash the Valley again. |
Bio-IT World
March 17, 2004 |
Signs of Spring Colin Hill, CEO of Gene Network Sciences, a predictive systems biology company, says the worst is behind the bio-IT industry. "The hype has dissipated, and companies are focused on delivering the results," he says. Hill's strategy includes developing additional products, which should generate near-term revenue. |
Entrepreneur
April 2009
Brad Feld |
Beware the Arrogant Venture Capitalist Their weaknesses may vary, but there's typically a common characteristic not-great venture capitalists share: arrogance. |
Bio-IT World
January 21, 2005 |
The Other Guy's Shoes The assessment of vendor risk is a process both investors and customers must go through. How the entrepreneur manages their questions will determine if the company gets the proper funding it needs to properly sell product. |
Investment Advisor
April 2010
Jeff Joseph |
Venture Populist: The Venture Investor's Put Option How to increase the range of returns for private investments. |
Entrepreneur
July 2002
Tracy T. Lefteroff |
After The Flood With the flow of VC funding slowed to a trickle, let our list of the top 100 VC funds be your divining rod. |
Entrepreneur
August 2008
Tracy T. Lefteroff |
High Rollers Venture capitalists showed entrepreneurs the big bucks in 2007. Could one of our top VC firms be looking for a business like yours this time around? |
Inc.
February 2006
Darren Dahl |
Facing the Capital Gap There's plenty of capital out there. So why are so many companies struggling to raise money? |
Entrepreneur
May 2002
C.J. Prince |
Springing Back It's not a mirage. The end to the long VC investment dry spell is within your reach... |
Entrepreneur
May 2003
C.J. Prince |
Ray of Hope? VCs are optimistic about the coming year but are still holding on to their purse strings. |
Salon.com
July 19, 2000
Janelle Brown & Katharine Mieszkowski |
Score: Men 97, Women 3 Men entrepreneurs still receive almost all the venture capital. What will it take for women to catch up? |
HBS Working Knowledge
November 29, 2006
Sarah Jane Gilbert |
Rich or Royal: What Do Founders Want? Entrepreneurs are often motivated by the potential of money and control, but very few ever achieve both. |
Entrepreneur
May 2004
C.J. Prince |
Ready, Set, Flow Optimistic entrepreneurs are testing the VC waters now that the market's future looks brighter. |
Entrepreneur
April 2010
Brad Feld |
Know When to Walk Away Don't ask venture capitalists for referrals if they say they're not interested. |
Fast Company
Vivian Giang |
Why The Few Women Venture Capitalists Often Give Up Only 2.7% of all venture-backed companies have a woman CEO. That's 183 out of 6,517 companies or $1.5 billion out of the $50.8 billion invested between 2011 and 2013. |
HBS Working Knowledge
December 7, 2009
Sean Silverthorne |
Government's Positive Role in Kick-Starting Entrepreneurship Professor Josh Lerner, author Boulevard of Broken Dreams, wonders if its time for Uncle Sam to invest in new entrepreneurial firms. |
Entrepreneur
November 2003
David Worrell |
Seed Money VC financing for early-stage companies is back in bloom. |
Entrepreneur
December 2002
C.J. Prince |
No Mercy Are VCs sucking the life out of your business? Maybe you're better off without them. |
AskMen.com
July 25, 2002
Ian Harrison |
How To Write A Business Plan: Part 1 A business plan will act as a guide to a potential investor and indicate whether your venture is worth the capital risk. |
Bio-IT World
June 2006
Michael A. Greeley |
Backwards Influence Biotech companies must think downstream as they consider what drugs to develop. Many companies are introducing cost-effectiveness analysis earlier in the discovery process. |
InternetNews
October 4, 2004
Clint Boulton |
Minor Starts $50M Software On-Demand Fund Internet business entrepreneur Halsey Minor has set up a $50 million venture capital fund for piping applications over the Web as subscription services. |
Entrepreneur
July 2003
Lefteroff et al. |
The Thrill of the Chase Nowadays, it seems venture capitalists are an endangered species, but your chances of finding VC funding are better than you think. We'll help you track down investors with our 3rd Annual VC 100. |
IEEE Spectrum
April 2005
Stuck & Weingarten |
How Venture Capital Thwarts Innovation The tech bubble saw an explosion of VC-funded start-ups, but has more funding brought more innovation or less? You may be shocked, as they were, by what these researchers found. |
Investment Advisor
February 1, 2011
Jeff Joseph |
A Great (and Surprising) Venture Investment Source Many financial advisors are beginning to venture into venture. |
Entrepreneur
February 2004
David Worrell |
Safe Bet Federal funds are motivating VCs to invest in security firms. |
Bio-IT World
November 14, 2003
Michael Greeley |
Show You the Money Venture capitalists need to balance two, at times conflicting, parameters when considering compensation for the executives at biotech companies in their portfolios: cash and long-term equity incentives. |
Entrepreneur
July 2002
Mark Henricks |
Answering the Call Trust corporations to know when the VC game is ready for new players. |
Bio-IT World
September 2005
Michael A. Greeley |
Harvesting Patient Data Longitudinal data tools will allow pharmaceuticals to optimize sales force deployments and distribution strategies based on medical impacts of their compounds across various population sets. |
Bio-IT World
October 2005
Michael A. Greeley |
Biomarkers Redux How the biomarker discovery industry evolves is still under debate. It is clear that many approaches will need to coexist to give a complete understanding of a particular sample; this troubles many VCs, as small and emerging markets are not good at supporting numerous competing solutions. |
Bio-IT World
June 17, 2004
Michael A. Greeley |
A Bet on Biomarkers Biomarkers are a hot topic among venture capitalists these days and while they are becoming increasingly important in drug discovery and delivery processes, there is great debate about the best business models for marketing the related tools. |
Fast Company
May 2005
Alison Overholt |
Venturing Forth Kathy Sherbrooke, co-founder of Circles, one of the few venture-backed companies on our list, on what she learned about going after venture capital. |
Inc.
September 2008 |
Start-Up Capital Survey results about how start-ups obtain funding. |
Investment Advisor
August 2010
Jeff Joseph |
Venture Populist: Terms of Engagement for Private Venture Advisors Angel and venture investors often have the option to determine to what extent they intend to contribute professionally to their new portfolio holding. |
Entrepreneur
November 2001
C.J. Prince |
In-Out Privileges Is your business a revolving door for limited partners? As long as the money is there, don't worry if they come and go as they please... |
HBS Working Knowledge
February 18, 2013
Sean Silverthorne |
Breaking Through a Growth Stall Many companies get stuck on a plateau, unable to grow and burning through cash at a frightening rate. Frank V. Cespedes discusses how focusing on the right customers can generate growth again. |
